Evidence map›Paper›PMID 38143755›Full record

ArticleFrontiers in immunology2023

Corrigendum: Treatment of surgical brain injury by immune tolerance induced by peripheral intravenous injection of biotargeting nanoparticles loaded with brain antigens.

Zhen Tian, Lixia Xu, Qian Chen, Ruoyang Feng, Hao Lu, Huajun Tan, Jianming Kang, Yinsong Wang, Hua Yan

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhen Tian *Graduate School of Tianjin Medical University, Tianjin, China.
Lixia Xu *Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China.
Qian Chen *Graduate School of Tianjin Medical University, Tianjin, China.
Ruoyang FengGraduate School of Tianjin Medical University, Tianjin, China.
Hao LuGraduate School of Tianjin Medical University, Tianjin, China.
Huajun TanGraduate School of Tianjin Medical University, Tianjin, China.
Jianming KangDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Yinsong WangTianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), Research Center of Basic Medical Science, School of Pharmacy, Tianjin Medical University, Tianjin, China.
Hua YanTianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China.
Tianjin Medical University · CNTianjin Huanhu Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.00743.].

Indexed as

biotargeting nanoparticlesimmune tolerancemyelin basic proteinPBAE/PLGA nanoparticlessurgical brain injury

Identifiers

PMID38143755
PMCPMC10740370
OpenAlexW4389487447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.